Ascendis Pharma A/S (ASND) Earnings Date, Estimates & Call Transcripts

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)

Free asnd Stock Alerts

$145.23

-0.81 (-0.55%)

(As of 04/15/2024 ET)

Compare

Upcoming Earnings Date: Apr. 25Estimated
Actual EPS (Feb. 7): -$1.66 Beat By $0.49
Consensus EPS (Feb. 7): -$2.15

Earnings Per Share Revenue

ASND Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ASND Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Market Moving Trends

Top 5 AI Stocks to Buy for 2024

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Ascendis Pharma A/S Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($2.16)	($2.16)	($2.16)
Q2 2024	2	($1.76)	($1.07)	($1.42)
Q3 2024	2	($1.40)	($0.50)	($0.95)
Q4 2024	2	($0.95)	($0.17)	($0.56)
FY 2024	7	($6.27)	($3.90)	($5.09)

ASND Earnings Date and Information

Ascendis Pharma A/S last released its quarterly earnings results on February 7th, 2024. The biotechnology company reported ($1.66) earnings per share for the quarter, beating the consensus estimate of ($2.15) by $0.49. The firm had revenue of $148.62 million for the quarter, compared to analyst estimates of $97.02 million. Ascendis Pharma A/S has generated ($9.25) earnings per share over the last year (($9.25) diluted earnings per share). Earnings for Ascendis Pharma A/S are expected to grow in the coming year, from ($4.18) to ($0.42) per share. Ascendis Pharma A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 25th, 2024 based off prior year's report dates.

Ascendis Pharma A/S Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
4/25/2024 Estimated)	-	-	-	-	-	-	-
2/7/2024	Q4 2023	($2.15)	($1.66)	+$0.49	($1.66)	$97.02 million	$148.62 million
11/7/2023	Q3 2023	($2.63)	($3.12)	($0.49)	($3.12)	$52.54 million	$52.02 million
9/5/2023	Q2 2023	($2.68)	($2.35)	+$0.33	($2.35)	$41.73 million	$51.59 million
4/27/2023	Q1 2023	($2.84)	($2.12)	+$0.72	($2.12)	$24.53 million	$36.04 million
2/16/2023	Q4 2022	($2.50)	($3.78)	($1.28)	($3.78)	$20.31 million	$23.38 million
11/2/2022	Q3 2022	($2.52)	($3.05)	($0.53)	($3.05)	$10.67 million	$15.41 million
Get the Latest News and Ratings for ASND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.
8/10/2022	Q2 2022	($2.11)	($1.54)	+$0.57	($1.54)	$7.07 million	$6.51 million
5/11/2022	Q1 2022	($2.25)	($2.48)	($0.23)	($2.48)	$5.89 million	$7.66 million
3/2/2022	Q4 2021	($2.57)	($2.14)	+$0.43	($2.14)	$2.78 million	$5.60 million
11/9/2021	Q3 2021	($2.60)	($1.47)	+$1.13	($1.73)	$1.60 million	$1.31 million
8/24/2021	Q2 2021	($2.75)	($2.50)	+$0.25	($3.01)	$1.46 million	$1.23 million
5/26/2021	Q1 2021	($2.06)	($1.17)	+$0.89	($1.41)	$1.94 million	$0.90 million

Ascendis Pharma A/S Earnings - Frequently Asked Questions

When is Ascendis Pharma A/S's earnings date?: Ascendis Pharma A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 25th, 2024 based off last year's report dates. Learn more on ASND's earnings history.
Did Ascendis Pharma A/S beat their earnings estimates last quarter?: In the previous quarter, Ascendis Pharma A/S (NASDAQ:ASND) reported ($1.66) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.15) by $0.49. Learn more on analysts' earnings estimate vs. ASND's actual earnings.

How much revenue does Ascendis Pharma A/S generate each year?: Ascendis Pharma A/S (NASDAQ:ASND) has a recorded annual revenue of $288.08 million.
How much profit does Ascendis Pharma A/S generate each year?: Ascendis Pharma A/S (NASDAQ:ASND) has a recorded net income of -$521.07 million. ASND has generated -$9.25 earnings per share over the last four quarters.
What is Ascendis Pharma A/S's EPS forecast for next year?: Ascendis Pharma A/S's earnings are expected to grow from ($4.18) per share to ($0.42) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:ASND) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ascendis Pharma A/S (ASND) Earnings Date, Estimates & Call Transcripts

ASND Earnings Estimates and Actuals by Quarter

ASND Estimated and Actual Revenue by Quarter

Ascendis Pharma A/S Analyst EPS Estimates

ASND Earnings Date and Information

Ascendis Pharma A/S Earnings History by Quarter

Ascendis Pharma A/S Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ascendis Pharma A/S (ASND) Earnings Date, Estimates & Call Transcripts

Earnings Summary

ASND Earnings Estimates and Actuals by Quarter

ASND Estimated and Actual Revenue by Quarter

Ascendis Pharma A/S Analyst EPS Estimates

ASND Earnings Date and Information

Ascendis Pharma A/S Earnings History by Quarter

Ascendis Pharma A/S Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat